These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 35190590)
1. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects. Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590 [TBL] [Abstract][Full Text] [Related]
2. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873 [TBL] [Abstract][Full Text] [Related]
3. [Immunity against SARS-CoV-2: walking to the vaccination]. Rodríguez Hernández C; Sanz Moreno L Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536 [TBL] [Abstract][Full Text] [Related]
4. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
5. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia. McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236 [TBL] [Abstract][Full Text] [Related]
6. Herd immunization with childhood vaccination may provide protection against COVID-19. Yu Y Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity. Blasi F; Gramegna A; Sotgiu G; Saderi L; Voza A; Aliberti S; Amati F Respir Med; 2021; 180():106355. PubMed ID: 33721697 [TBL] [Abstract][Full Text] [Related]
9. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract. Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008 [TBL] [Abstract][Full Text] [Related]
10. Impact of vaccination on the COVID-19 pandemic in U.S. states. Chen X; Huang H; Ju J; Sun R; Zhang J Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640 [TBL] [Abstract][Full Text] [Related]
11. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave. Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials. Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768 [TBL] [Abstract][Full Text] [Related]
14. Modelling COVID-19 dynamics and potential for herd immunity by vaccination in Austria, Luxembourg and Sweden. Kemp F; Proverbio D; Aalto A; Mombaerts L; Fouquier d'Hérouël A; Husch A; Ley C; Gonçalves J; Skupin A; Magni S J Theor Biol; 2021 Dec; 530():110874. PubMed ID: 34425136 [TBL] [Abstract][Full Text] [Related]
15. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection. Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L Front Immunol; 2021; 12():697074. PubMed ID: 34262569 [TBL] [Abstract][Full Text] [Related]
16. Quantifying indirect and direct vaccination effects arising in the SIR model. Lin L; Hamedmoghadam H; Shorten R; Stone L J R Soc Interface; 2024 Sep; 21(218):20240299. PubMed ID: 39288818 [TBL] [Abstract][Full Text] [Related]
17. The bumpy road to achieve herd immunity in COVID-19. Neagu M J Immunoassay Immunochem; 2020 Nov; 41(6):928-945. PubMed ID: 33086932 [TBL] [Abstract][Full Text] [Related]
18. Strategies for COVID-19 vaccination under a shortage scenario: a geo-stochastic modelling approach. Barreiro NL; Ventura CI; Govezensky T; Núñez M; Bolcatto PG; Barrio RA Sci Rep; 2022 Jan; 12(1):1603. PubMed ID: 35102216 [TBL] [Abstract][Full Text] [Related]
19. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity. Chun JY; Jeong H; Kim Y J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093 [TBL] [Abstract][Full Text] [Related]